肺免疫预后指数与特发性间质性肺炎患者生存的关联
多中心回顾性观察研究探讨肺免疫预后指数(LIPI)与特发性间质性肺炎(IIPs)患者生存的关系。探索队列460例和验证队列414例中,IPF患者低LIPI较高LIPI生存显著更优,且在多变量分析中LIPI为IPF生存的独立预测因素;非IPF患者中无显著关联。
要点
- LIPI由血乳酸脱氢酶和衍生中性粒细胞与淋巴细胞比值计算,与宿主免疫状态相关。
- IPF患者低LIPI较高LIPI生存更优,探索队列中位5.6年vs 3.9年(p=0.016)。
- 验证队列证实IPF患者低LIPI生存更优,中位8.5年vs 4.4年(p=0.003)。
核心结论
- LIPI是IPF患者生存的预测因素,可能有助于IPF管理。
研究设计与样本
- 多中心、回顾性、观察性研究,探索队列460例IIPs患者,验证队列414例IIPs患者。
- 探索队列中IPF 159例、非IPF 301例;验证队列中IPF 159例、非IPF 255例。
主要发现
- 探索队列中IPF患者低LIPI较高LIPI生存显著更优,中位5.6年vs 3.9年(p=0.016)。
- 验证队列中IPF患者低LIPI较高LIPI生存显著更优,中位8.5年vs 4.4年(p=0.003)。
- 多变量Cox比例风险分析中,LIPI被选为IPF患者生存的独立预测因素。
- 探索队列和验证队列中,LIPI与非IPF患者生存均无显著关联。
临床怎么用
- LIPI可作为IPF患者生存预测的参考指标,辅助临床管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The lung immune prognostic index (LIPI), a simple index calculated from the blood lactate dehydrogenase level and derived neutrophil-to-lymphocyte ratio, is thought to be associated with host immune status. However, the utility of LIPI in patients with idiopathic interstitial pneumonias (IIPs) is unknown. METHODS: In this multicentre, retrospective, observational study, an association between LIPI and the survival of patients with IIPs was evaluated. RESULTS: Exploratory and validation cohorts consisting of 460 and 414 patients with IIPs, respectively, were included (159 and 159 patients had idiopathic pulmonary fibrosis [IPF], and 301 and 255 had non-IPF, respectively). In the exploratory cohort, patients with IPF and a low LIPI had significantly better survival than those with a high LIPI (median of 5.6 years vs. 3.9 years, p = 0.016). The predictive ability of LIPI for the survival of patients with IPF was validated in the validation cohort (median of 8.5 years vs. 4.4 years, p = 0.003). In a multivariate Cox proportional hazard analysis, LIPI was selected as an independent predictive factor for the survival of IPF patients. There was no significant association between LIPI and survival of non-IPF patients in the exploratory and validation cohorts. CONCLUSION: The LIPI was a predictive factor for the survival of patients with IPF and could aid the management of IPF.
引用
- Suzuki T, Karayama M, Aoshima Y, et al. Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumonias. Respirology. 2023. PMID: 37921012. doi:10.1111/resp.14621
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。